secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001213900-26-033832
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02, 8.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds US board and CEO ousted; new board approves expansion into Korean cosmetics and photo booth
--------------------------------------------------------------------------------

- Majority stockholders removed directors Elona Kogan, Jakap Koo, Carol O’Donnell, Dr. Bennett Weintraub via written consent.
- CEO Vin Menon and CFO Erick Frim removed; Youngjik Cho appointed CEO, Junyoung Yu as Secretary.
- New board approved non-binding MOUs with Assemble, Hilluck (cosmetics distribution) and LK Ventures (Life4Cuts photo booth platform).
- Company delays previously announced 1-for-10 reverse stock split; board will continue to evaluate timing.
- MindWave issued unauthorized press release challenging the consent; company intends to vigorously defend validity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026033832/0001213900-26-033832-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390026033832/ea0283355-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-033832

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer